Answers are grounded in this paper and cite their sources.
The findings support the avoidance of nCRT in low-risk patients and suggest that in high-risk patients, neoadjuvant therapy should be intensified to improve prognosis.
No takes yet. Share an insight, caveat, or question.
Ruppert et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: